Asazuma K, Shimomura A, Shimizu C. Antibody-Drug Conjugates as an Adjuvant Therapy for Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer. J Clin Oncol 2022 Apr 14:JCO2200135. doi: 10.1200/JCO.22.00135.
PMID: 35420886